Brought to you by 
Idorsia grosses $508.9mm in combined equity and debt offerings
11 Jul 2018
Executive Summary
Idorsia Pharmaceuticals Ltd. grossed CHF505mm ($508.9mm) in combined equity and debt offerings. The company placed 11.9mm new shares at CHF25.62 ($25.81) per share for gross proceeds of CHF305mm ($307.4mm) and simultaneously secured CHF200mm ($201.5mm) in senior convertible redeemable bonds.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- FOPO
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Idorsia grosses $508.9mm in combined equity and debt offerings
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice